Want to join the conversation?
$FDX reported higher earnings in 1Q17, helped by higher revenue compared to 1Q16. Net income was $715MM or $2.65 per diluted share compared to $692MM or $2.42 per diluted share last year. Revenue grew approx. 20% from last year to $14.7Bil. Adjusted net income was $780MM or $2.90 per diluted share in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?